To Compare Sweeping of Membranes Versus Expectant Management for Spontaneous Onset of Labor and Vaginal Delivery.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorMuhammad Aamir Latif

About this trial

The study is planned to fill the gaps regarding the effectiveness of sweeping of membranes versus expectant management in terms of spontaneous onset of labor and vaginal delivery in post-date primigravida.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Primigravid women

Aged between 18 and 40 years

Gestational age ≥40 weeks, confirmed by ultrasound or early dating scan

Singleton pregnancies

Disqualifiers

Multiple gestations

Fetal distress or anomalies detected on ultrasound

Contraindications to vaginal delivery (e.g., placenta previa, previous uterine surgery)

Previous uterine scar

Trial design

Design model

Parallel

Treatments tested in this trial

  • Membrane sweeping

    Procedure/Surgery

    Participants in the membranes sweeping group will receive membrane sweeping. If labor will not initiate within 48 hours, the procedure will be repeated up to a maximum of three times at 48-hour intervals.

Treatment groups

132 Participants
are divided into 2 treatment groups
Group A: Membrane sweeping groupExperimental treatment 1 intervention
Group B: Expectant management groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Spontaneous onset of labor and vaginal delivery

The occurrence of regular uterine contractions (contractions occurring every 3-5 minutes, each lasting 30-60 seconds, and progressively increasing in intensity) leading to cervical changes without any form of labor induction will mark the achievement of spontaneous onset of labor.

Time frame
6 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Muhammad Aamir Latif

Lead sponsor

RESnTEC, Institute of Research

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: